Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
Open Access
- 12 June 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 1097-1107
- https://doi.org/10.1016/j.omtm.2020.04.027
Abstract
No abstract availableFunding Information
- European Research Council (755758)
This publication has 42 references indexed in Scilit:
- Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickasesGenome Research, 2013
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificityNature Biotechnology, 2013
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activityNucleic Acids Research, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature Biotechnology, 2013
- Off-label, but on-target: Use of regadenoson with exerciseJournal of Nuclear Cardiology, 2013
- RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primersBMC Biotechnology, 2011
- CD34+ Stem Cells from Umbilical Cord BloodClinics and Practice, 2011
- Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an updateBlood Cancer Journal, 2011
- Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArchives of Disease in Childhood, 1997